# OnCo record germ-cell-tumour-markers (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/germ-cell-tumour-markers/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "germ-cell-tumour-markers" ;
  schema:name "AFP, hCG and LDH in germ cell tumours (IGCCCG risk groups)"@en ;
  schema:alternateName "germ cell tumour markers"@en, "IGCCCG classification"@en, "alpha-fetoprotein and beta-hCG"@en, "testicular cancer blood tests"@en ;
  schema:description "In testicular and other germ cell cancers three blood tests, AFP, beta-hCG and LDH, are part of the staging itself: their levels after surgery sort patients into good, intermediate and poor risk groups that fix how many cycles of chemotherapy they get, and their return to normal defines cure."@en ;
  schema:url <https://onco.cc/technologies/germ-cell-tumour-markers/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1200/JCO.20.03296> ;
  onco:status "standard-of-care" ;
  onco:cancers <https://onco.cc/cancers/testicular/>, <https://onco.cc/cancers/non-seminoma/>, <https://onco.cc/cancers/seminoma/>, <https://onco.cc/cancers/extragonadal-germ-cell-tumour/>, <https://onco.cc/cancers/paediatric-germ-cell-tumours/>, <https://onco.cc/cancers/gestational-trophoblastic/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/> ;
  onco:technologies <https://onco.cc/technologies/serum-tumour-markers/>, <https://onco.cc/technologies/thyroid-cancer-markers/>, <https://onco.cc/technologies/cea-surveillance-colorectal/>, <https://onco.cc/technologies/ct/> ;
  onco:drugs <https://onco.cc/drugs/cisplatin/> ;
  onco:terms <https://onco.cc/terms/afp/>, <https://onco.cc/terms/tumour-marker/>, <https://onco.cc/terms/tumour-markers/> .